Press Release: InBios : InBios Receives FDA EUA for COVID-19 IgG Antibody Rapid Test

InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Detect IgG Rapid Test, a qualitative immunoassay for the detection of IgG antibodies to SARS-CoV-2.(PRWeb September 15, 2021)Read the full story at https://www.prweb.com/releases/inbios_receives_fda_eua_for_covid_19_igg_antibody_rapid_test/prweb18163111.htm